Pfizer Discusses Rapid Approval Plan for COVID-19 Vaccine with India
[Asia Economy Reporter Kum Boryeong] It has been revealed that Pfizer, the U.S. pharmaceutical company producing the COVID-19 vaccine, is discussing rapid vaccine approval measures with the Indian government.
According to major foreign media, Albert Bourla, Pfizer's Chief Executive Officer (CEO), announced this on social media (SNS) on the 3rd (local time).
CEO Bourla explained, "The (vaccine approval) application was submitted several months ago, but unfortunately, it has not yet been approved in India."
Along with this, CEO Bourla announced that Pfizer would donate pharmaceuticals worth 70 million dollars to India.
The COVID-19 vaccines currently approved for use in India include AstraZeneca's 'Covishield,' Russia's 'Sputnik V,' and 'Covaxin,' which was independently developed by the Indian pharmaceutical company Bharat Biotech.
Hot Picks Today
"Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- "Striking Will Lead to Regret": Hyundai-Kia Employees Speak Out... Uneasy Stares Toward Samsung Union
- Man in His 40s Who Kept Girlfriend's Body for a Year After Murder Sentenced to 30 Years in Prison Again on Appeal
- Despite Captivating the Nation for Over a Month... "Timmy" the Whale Ultimately Found Dead
- "If You Booked This Month, You Almost Lost Out... Why You Should Wait Until 'This Day' Before Paying for Flight Tickets"
In India, the spread of the virus continues, with 392,488 new COVID-19 cases reported the previous day.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
